We invite you to RESTORE upcoming online event: Gene Therapy 2.0 on Wednesday 29th September 2021 at 14:00 h CEST
The afternoon event, hosted by RESTORE - Health by Advanced Therapies and chaired by Prof. Hildegard Büning (Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany), aims to engage and inform academic and industry institutions as well as patient networks, about the most recent updates and opportunities in gene therapy approaches.
More and more gene therapies are entering the market, for example Zynteglo (beta thalassemia), Luxturna (inherited retinal disease, Leber congenital amaurosis) and Strimvelis (severe combined immunodeficiency due to adenosine deaminase deficiency). This so-called “classical gene therapy” has established itself as a recognized alternative to older treatment modalities. However, scientists at the forefront of gene therapy research do not only think about the present, but also about the future, planning for the years ahead and already working to shape the next generation of gene therapies, expanding the realm of what will be scientifically and medically possible.
Join us online on 29th September 2021 to take a peek into the future with our international panel of speakers!
Hildegard Büning Institute of Experimental Hematology, Hannover Medical School, Germany, Nathalie Cartier Paris Brain Institute, University Hospital Pitié-Salpêtrière, France, Vincenzo Cerullo, Pharmaceutical Biosciences and Centre for Drug Research, Faculty of Pharmacy, University of Helsinki – Finland, Luigi Naldini San Raffaele Telethon Institute for Gene Therapy and San Raffaele University Medical School, Milan, Italy, Jude Samulski Gene Therapy Center, UNC School of Medicine, United States, Axel Schambach Institute of Experimental Hematology, Hannover Medical School, Germany and Hans-Dieter Volk Institute for Med. Immunology, BIH Centre of Regenerative Therapy, Charité Universitaetsmedizin Berlin, Germany
